St. Jude Children's Research Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1962-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.stjude.org/
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
Phase 2
Active, not recruiting
- Conditions
- Interventions
- Drug: VincristineDrug: DactinomycinDrug: CyclophosphamideProcedure: Surgical ResectionProcedure: RadiationDrug: Myeloid Growth FactorDrug: BevacizumabProcedure: Lymph Node SamplingDrug: SorafenibDrug: ^1^1C-methionineDrug: IrinotecanDrug: IfosfamideDrug: EtoposideDrug: Etoposide PhosphateDrug: DoxorubicinDrug: Dexrazoxane
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 98
- Registration Number
- NCT01871766
- Locations
- 🇺🇸
Nemours Children's Clinic, Jacksonville, Florida, United States
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸University of Florida Proton Therapy Institute, Jacksonville, Florida, United States
Therapy for Children With Advanced Stage Neuroblastoma
Phase 2
Active, not recruiting
- Conditions
- Interventions
- Drug: cyclophosphamideDrug: topotecanBiological: hu14.18K322AProcedure: peripheral blood stem cell harvestProcedure: surgical resectionDrug: cisplatinDrug: etoposideDrug: doxorubicinDrug: vincristineDrug: busulfanDrug: melphalanBiological: peripheral blood stem cell transplantationBiological: natural killer cell infusionRadiation: radiation therapyBiological: GM-CSFBiological: G-CSFDrug: mesnaDrug: levetiracetamBiological: interleukin-2Drug: IsotretinoinDevice: CliniMACS
- First Posted Date
- 2013-05-20
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 153
- Registration Number
- NCT01857934
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-05-08
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01849393
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-03-28
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 416
- Registration Number
- NCT01820117
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy
- First Posted Date
- 2013-03-08
- Last Posted Date
- 2022-10-31
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 82
- Registration Number
- NCT01807611
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
Phase 2
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 174
- Registration Number
- NCT01783535
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
A Web-Based Physical Activity Intervention in Adolescent Survivors of Childhood Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-01-29
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 105
- Registration Number
- NCT01778127
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Catheter Resistance Monitoring to Predict Catheter-Associated Adverse Events in Children and Adolescents
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01737554
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 133
- Registration Number
- NCT01701492
- Locations
- 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Phase 2
Completed
- Conditions
- Interventions
- Drug: dexamethasoneDrug: vincristine sulfateBiological: rituximabDrug: clofarabineDrug: cyclophosphamideDrug: etoposideBiological: aldesleukinDrug: pegaspargaseDrug: methotrexateDrug: mercaptopurineDrug: cytarabineDrug: mitoxantroneDrug: teniposideDrug: vinblastineBiological: natural killer cell infusionOther: laboratory biomarker analysisProcedure: allogeneic hematopoietic stem cell transplantationDrug: therapeutic hydrocortisoneDevice: CliniMACS
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- St. Jude Children's Research Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01700946
- Locations
- 🇺🇸
Rady Children's Hospital and Health Center, San Diego, California, United States
🇺🇸St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸Cook Children's Medical Center, Fort Worth, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath